Previous 10 | Next 10 |
home / stock / amgn / amgn articles
On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) has 12% free cash flow yield...
Raymond James has resumed coverage of Amgen Inc (NASDAQ:AMGN), noting a diversified portfolio where Amgen has a strong presence that...
In a move outlined in his upcoming State of the Union address, President Joe Biden is pushing for an increase in the number of prescripti...
Amgen Inc (NASDAQ:AMGN) is expected to unveil updates on various programs this year, targeting significant markets. Despite concern...
BeiGene (NASDAQ: BGNE) is expected to report its fourth-quarter 2023 results soon. BeiGene currently markets three internally discovered oncology p...
Tuesday, Amgen Inc (NASDAQ:AMGN) reported its fourth quarter 2023 adjusted net profit increased 15% to $4.71, beating the consensus of $4...
U.S. stocks are poised for another day of weakness, although some positive tech earnings may provide a modest lift to the sector. The market appe...
Tuesday, Johnson & Johnson (NYSE:JNJ) released better-than-expected earnings for its fourth quarter of 2023. It reported quarterly adjusted e...
The FDA has added a serious warning to the prescribing information for Amgen Inc’s (NASDAQ:AMGN) drug Prolia (denosumab), emphasizi...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 08:45:00 ET If there is one thing income investors like more than regular dividend payouts, it's regular and growing dividend payouts. Not every corporation can offer that, of course. Some will eventually suspend their dividend programs or, at the very least, decrease their p...
PALM BEACH, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is among the most frequently diagnosed and the seventh leading cause of cancer death globally. Pancreatic cancer becomes more common in the Western world. The prevalence rate of panc...
2024-06-20 08:15:00 ET Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500 's 90% gain over that stretch. With some promising products in its pipeline, the future does looks encouraging. However, s...